BOCCANEGRA, BRIGIDA
 Distribuzione geografica
Continente #
NA - Nord America 1.005
EU - Europa 698
AS - Asia 686
SA - Sud America 165
AF - Africa 38
OC - Oceania 2
Totale 2.594
Nazione #
US - Stati Uniti d'America 930
IT - Italia 367
SG - Singapore 307
BR - Brasile 126
CN - Cina 113
HK - Hong Kong 73
DE - Germania 63
RU - Federazione Russa 61
VN - Vietnam 60
CA - Canada 50
FR - Francia 39
GB - Regno Unito 37
FI - Finlandia 26
SE - Svezia 24
ID - Indonesia 23
ES - Italia 21
IN - India 21
MX - Messico 20
BD - Bangladesh 18
NL - Olanda 15
JP - Giappone 13
CI - Costa d'Avorio 12
AR - Argentina 11
IQ - Iraq 11
AT - Austria 8
TR - Turchia 8
CZ - Repubblica Ceca 7
MA - Marocco 7
PK - Pakistan 7
ZA - Sudafrica 7
PL - Polonia 6
UA - Ucraina 6
CO - Colombia 5
PE - Perù 5
VE - Venezuela 5
CL - Cile 4
JO - Giordania 4
TW - Taiwan 4
UZ - Uzbekistan 4
EC - Ecuador 3
IE - Irlanda 3
KE - Kenya 3
MY - Malesia 3
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
KR - Corea 2
NI - Nicaragua 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BT - Bhutan 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
UY - Uruguay 1
Totale 2.594
Città #
Singapore 185
Ashburn 144
San Jose 112
Bari 110
Dallas 71
Hong Kong 71
Milan 66
Chandler 44
Beijing 39
Council Bluffs 38
Fairfield 29
Los Angeles 29
Victoria 28
Jakarta 20
Rome 20
Falkenstein 19
New York 19
Nyköping 19
Helsinki 17
Lauterbourg 17
Hanoi 16
Seattle 16
Woodbridge 15
Columbus 14
Taranto 14
Cambridge 13
Frankfurt am Main 13
Ho Chi Minh City 13
Houston 13
Munich 13
Abidjan 12
Boardman 11
Mexico City 11
Santa Clara 11
Nuremberg 10
Brooklyn 9
São Paulo 9
Naples 8
Turku 8
Wilmington 8
Chicago 7
North Bergen 7
Trieste 7
Brno 6
Buffalo 6
Chennai 6
Denver 6
Des Moines 6
Lawrence 6
London 6
Montreal 6
Rio de Janeiro 6
Toronto 6
Amsterdam 5
Ann Arbor 5
Inglewood 5
Nakano 5
Stockholm 5
Turin 5
Aldeatejada 4
Ankara 4
Baghdad 4
Brescia 4
Casablanca 4
Dong Ket 4
Düsseldorf 4
Luton 4
Miano 4
Modugno 4
Moscow 4
Orem 4
Portsmouth 4
Shanghai 4
Tokyo 4
Albairate 3
Atlanta 3
Barletta 3
Bauru 3
Belo Horizonte 3
Boston 3
Brasília 3
Campinas 3
Caracas 3
Dublin 3
Goiânia 3
Haiphong 3
Johannesburg 3
Princeton 3
Quận Bình Thạnh 3
Roxbury 3
Santa Maria 3
Santiago de Compostela 3
St Louis 3
São José 3
Tampa 3
Tashkent 3
Vienna 3
Warsaw 3
Wroclaw 3
Adelfia 2
Totale 1.582
Nome #
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 339
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 213
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 155
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 155
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 122
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 120
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 119
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks 117
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 114
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 114
Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy 110
Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. 104
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 98
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 95
The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam 89
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model 87
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets 85
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 83
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 79
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence 46
PRE-CLINICAL ASSESSMENT OF THE ROLE OF THE COMPLEMENT SYSTEM IN TRIGGERING FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY: TOWARDS NOVEL THERAPEUTIC TARGETS 37
Investigation of genotype-phenotype correlation in 2D cell models of Duchenne muscular dystrophy patients shows mutation-dependent defects in mitochondrial respiration and delay in myogenic program 34
Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp 33
SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure 30
Patient-Oriented In Vitro Studies in Duchenne Muscular Dystrophy: Validation of a 3D Skeletal Muscle Organoid Platform 25
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 25
Cell lines of Duchenne Muscular dystrophy patients shows mutation-dependent delay in myogenic program 19
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 16
Best reference genes for unbiased normalized transcript expression in normal and dystrophic human cell models of myogenesis 11
254PActivation of complement cascade may trigger inflammation and fibrosis in Duchenne muscular dystrophy: a preclinical investigation on two murine models 6
Electrical impedance myography as a tool for monitoring disease progression in mouse models of Duchenne Muscular Dystrophy: a longitudinal, multisite study 5
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 5
Drug repurposing based on integrated in silico and in vitro approach to find a therapy for KCNA2-related disorders 4
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 4
Branched-chain amino acid supplementation in a mouse model of ageing: Effects on age-related kidney fibrosis 4
From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders 4
Totale 2.706
Categoria #
all - tutte 9.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202252 4 0 2 0 0 2 8 0 5 7 11 13
2022/2023116 9 16 7 10 8 10 7 11 17 1 11 9
2023/2024101 2 16 7 10 6 17 1 4 7 15 6 10
2024/2025597 11 0 12 12 8 71 117 79 43 44 78 122
2025/20261.566 182 57 165 115 194 73 165 63 200 163 90 99
2026/2027143 143 0 0 0 0 0 0 0 0 0 0 0
Totale 2.706